HIV and hepatitis C virus co-infection.
暂无分享,去创建一个
[1] Michael S Saag,et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. , 2002, JAMA.
[2] M. Rela,et al. Liver transplantation in adults coinfected with HIV. , 2001, Transplantation.
[3] P. Morlat,et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) , 2003, AIDS.
[4] M. L. Rodriguez-Mendez,et al. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. , 2003, Hepato-gastroenterology.
[5] R. Byers,et al. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. , 2002 .
[6] Frank Scholle,et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. , 2002, Gastroenterology.
[7] A. Lafeuillade,et al. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection , 2001, The Lancet.
[8] V. Soriano,et al. Care of patients with hepatitis C and HIV co-infection. , 2004, AIDS.
[9] M. Keller,et al. Solid organ transplantation in HIV‐infected recipients , 2004, Pediatric transplantation.
[10] A. Tzakis,et al. Liver transplantation for HIV-infected patients with end-stage liver disease , 2002 .
[11] M. Kazatchkine,et al. Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients , 2001 .
[12] V. Soriano,et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C , 2001, American Journal of Gastroenterology.
[13] T. Santantonio,et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. , 1999, Gastroenterology.
[14] D. Snydman,et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] F. Donato,et al. Mortality for liver disease in patients with HIV infection: a cohort study. , 2000, Journal of acquired immune deficiency syndromes.
[16] Richard D Moore,et al. Hepatitis C and progression of HIV disease. , 2002, JAMA.
[17] M. Urdea,et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections , 1993, Journal of clinical microbiology.
[18] G. Lüchters,et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection , 2003, The Lancet.
[19] S. Sauleda,et al. Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus–infected patients with congenital coagulation disorders , 2001, Hepatology.
[20] V. Soriano,et al. Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment. , 2002, AIDS.
[21] M. Leal,et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. , 1997, Journal of hepatology.
[22] D. Tolan,et al. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. , 2001, The New England journal of medicine.
[23] J. Castilla,et al. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group. , 1997, The American journal of gastroenterology.
[24] J. Fung,et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[25] Miriam J. Alter. Epidemiology of hepatitis C. , 1996 .
[26] R. Talamini,et al. Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin , 2001, AIDS.
[27] C. Quereda,et al. Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients , 2003, AIDS.
[28] R. Chung,et al. Rapidly progressive fibrosing cholestatic hepatitis-hepatitis C virus in HIV coinfection , 2002, American Journal of Gastroenterology.
[29] J. Rockstroh,et al. Antiretroviral drug toxicity -- a challenge for the hepatologist? , 2002, Journal of hepatology.
[30] T. Sauerbruch,et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. , 1996, The American journal of gastroenterology.
[31] C. Sabin,et al. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. , 1997, The Journal of infectious diseases.
[32] A. Zanetti,et al. Mother-to-infant transmission of hepatitis C virus , 1995, The Lancet.
[33] J. González-lahoz,et al. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients. , 2001, AIDS research and human retroviruses.
[34] H. Jessen,et al. Treatment of acute hepatitis C infection in HIV‐infected patients: a retrospective analysis of eleven cases , 2005, Journal of viral hepatitis.
[35] M. Vogel,et al. Management of drug‐to‐drug interactions between cyclosporine A and the protease‐inhibitor lopinavir/ritonavir in liver‐transplanted HIV‐infected patients , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[36] J. George,et al. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response , 2002, Hepatology.
[37] F. Carnot,et al. Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] S. Darby,et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C , 1997, The Lancet.
[39] M. Leal,et al. Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired Hepatitis C , 1995, European Journal of Clinical Microbiology and Infectious Diseases.
[40] Yoshiharu Matsuura,et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.
[41] R. Roldán,et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] R. Chung,et al. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] M. Lowdell,et al. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[44] P. Marcellin,et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. , 2004, Annals of internal medicine.
[45] G. Feldmann,et al. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5 , 2004, Journal of viral hepatitis.
[46] J. Fung,et al. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. , 1999, Blood.
[47] J. Rakela,et al. Human immunodeficiency virus facilitates infection/replication of hepatitis C virus in native human macrophages. , 2004, Blood.
[48] R. Schooley,et al. Ribavirin antagonizes the effect of azidothymidine on HIV replication , 1987, Science.
[49] Jiirgen Kurt Rockstroh. Management of Hepatitis B and C in HIV Co-Infected Patients , 2003, Journal of acquired immune deficiency syndromes.
[50] A. Telenti,et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. , 2003, Archives of internal medicine.
[51] A. Balasubramanian,et al. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. , 2003, The Journal of infectious diseases.
[52] J. J. de la Cruz,et al. Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[53] R. Kaiser,et al. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. , 1998, AIDS.
[54] A. Lok,et al. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs , 1996, Digestive Diseases and Sciences.
[55] J. Goedert,et al. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.
[56] A. Alberti,et al. Hepatitis C virus genotypes and severity of chronic liver disease in haemophiliacs , 1995, British journal of haematology.
[57] F. Lunel,et al. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection. , 1999, The Journal of infectious diseases.
[58] Kenneth Koury,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[59] D. Dieterich,et al. Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] G. Berlakovich. Clinical Outcome of Orthotopic Liver Transplantation , 2002, The International journal of artificial organs.
[61] E. Tanzi,et al. Mother-to-infant transmission of hepatitis C virus. , 1999, Journal of hepatology.
[62] R. Chaisson,et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. , 2000, JAMA.
[63] J. Rodríguez-Orengo,et al. 91 Control of HIV viral load through highly active antiretroviral therapy (HAART) slows down liver fibrosis progression in HIV/HCV-coinfection and makes it the same as in HCV-monoinfection. The Puerto Rico-New York hepatitis C study group , 2004 .
[64] Fiedler,et al. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C , 1998, Histopathology.
[65] P. Couzigou,et al. Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA). , 1999, AIDS.
[66] D. Pessayre,et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] P. Reiss,et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection , 2000, AIDS.
[68] G. Davis,et al. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. , 1994, Gastroenterology.
[69] J. Goedert,et al. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection. , 2001, The Journal of infectious diseases.
[70] V. Soriano,et al. Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy. , 2000, AIDS.
[71] M. Battegay,et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study , 2000, The Lancet.
[72] D. Margolis,et al. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. , 2002, Antiviral research.
[73] V. Soriano,et al. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel. , 2002, AIDS.
[74] L. Chauvelot‐Moachon,et al. Mitochondrial toxic effects and ribavirin , 2001, The Lancet.
[75] V. Lotteau,et al. Differential effect of ritonavir and indinavir on immune response to hepatitis C virus in HIV-1 infected patients. , 1999, AIDS.
[76] C. Katlama,et al. Factors affecting liver fibrosis in human immunodeficiency virus–and hepatitis C virus–coinfected patients: Impact of protease inhibitor therapy , 2001, Hepatology.
[77] J. Rockstroh,et al. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients. , 1999, AIDS.
[78] R. Byers,et al. Trends in Diseases Reported on U.S. Death Certificates That Mentioned HIV Infection, 1987‐1999 , 2002, Journal of acquired immune deficiency syndromes.
[79] M. Shullo,et al. Tacrolimus and Lopinavir/Ritonavir Interaction in Liver Transplantation , 2003, The Annals of pharmacotherapy.
[80] M. Gambardella,et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity , 2001, Hepatology.
[81] T. Ferraro,et al. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. , 1998, AIDS.
[82] T. Starzl,et al. Liver transplantation in a hemophiliac. , 1985, The New England journal of medicine.
[83] J. Goedert,et al. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. , 1994, Blood.
[84] J. Montaner,et al. Hepatotoxicity of nucleoside reverse transcriptase inhibitors. , 2003, Seminars in liver disease (Print).
[85] R. Chung,et al. IMMUNE RECOVERY IS ASSOCIATED WITH PERSISTENT RISE IN HEPATITIS C VIRUS RNA, INFREQUENT LIVER TEST FLARES, AND IS NOT IMPAIRED BY HEPATITIS C VIRUS IN CO-INFECTED SUBJECTS , 2002, AIDS.
[86] E. Schiff,et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[87] C. Trautwein,et al. Treatment of acute hepatitis C with interferon alfa-2b. , 2001, The New England journal of medicine.
[88] V. Soriano,et al. Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients , 2003 .
[89] C. Katlama,et al. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. , 2002, AIDS.
[90] Andrew Phillips,et al. Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy , 2001, AIDS.
[91] J. Patterson,et al. Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase. , 1990, Molecular pharmacology.
[92] A. Kirn,et al. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV , 1995, AIDS.
[93] A. Kirn,et al. Role of endogenous interferon in hepatitis C virus (HCV) infection and in coinfection by HIV and HCV. , 1996, Research in virology.
[94] R. Schvarcz,et al. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). , 2000, Transplantation.